Exact Mass: 536.3573667999999
Exact Mass Matches: 536.3573667999999
Found 402 metabolites which its exact mass value is equals to given mass value 536.3573667999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hyperforin
Hyperforin is a cyclic terpene ketone that is a prenylated carbobicyclic acylphloroglucinol derivative produced by St. Johns Wort, Hypericum perforatum. It has a role as a GABA reuptake inhibitor, a plant metabolite, an anti-inflammatory agent, an antidepressant, an antibacterial agent, an antineoplastic agent and an apoptosis inducer. It is a cyclic terpene ketone, a sesquarterpenoid and a carbobicyclic compound. Hyperforin is a phytochemical generated by the plants of the Hypericum family. One of the most important members of this family, due to its medical properties, is Hypericum perforatum, also known as St Johns wort. Hyperforin is a natural product found in Hypericum linarioides, Hypericum rumeliacum, and other organisms with data available. Hyperforin is found in alcoholic beverages. Hyperforin is a constituent of Hypericum perforatum (St Johns Wort) Hyperforin is a phytochemical produced by some of the members of the plant genus Hypericum, notably Hypericum perforatum (St Johns wort). The structure of hyperforin was elucidated by a research group from the Shemyakin Institute of Bio-organic Chemistry (USSR Academy of Sciences in Moscow) and published in 1975. Hyperforin is a prenylated phloroglucinol derivative. Total synthesis of hyperforin has not yet been accomplished, despite attempts by several research groups Constituent of Hypericum perforatum (St Johns Wort)
Cyclopassifloic acid A
Cyclopassifloic acid A is found in fruits. Cyclopassifloic acid A is a constituent of Passiflora edulis (passion fruit) Constituent of Passiflora edulis (passion fruit). Cyclopassifloic acid A is found in fruits.
Cyclopassifloic acid C
Cyclopassifloic acid C is found in fruits. Cyclopassifloic acid C is a constituent of Passiflora edulis (passion fruit)
Cyclotricuspidogenin C
Cyclotricuspidogenin B is found in fruits. Cyclotricuspidogenin B is isolated from Passiflora edulis (passion fruit).
LysoPA(a-25:0/0:0)
LysoPA(a-25:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(a-25:0/0:0), in particular, consists of one chain of anteisopentacosanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.
PA(8:0/16:0)
PA(8:0/16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/16:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(10:0/i-14:0)
PA(10:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-14:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(8:0/i-16:0)
PA(8:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-16:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
PA(i-12:0/i-12:0)
PA(i-12:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-12:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.
Cholyllysine
C30H52N2O6 (536.3825171999999)
Cholyllysine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholyllysine consists of the bile acid cholic acid conjugated to the amino acid Lysine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholyllysine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholyllysine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
Cholylglutamine
Cholylglutamine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylglutamine consists of the bile acid cholic acid conjugated to the amino acid Glutamine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylglutamine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylglutamine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).
2,3,7,8,12,13,17,18-Octaethyl-21,22,23,24-tetrahydroporphyrin
(1R,5R,6R,7S)-6-Methyl-1,3,7-tris(3-methylbut-2-enyl)-5-(2-methyl-1-oxopropyl)-6-(4-methylpent-3-enyl)bicyclo[3.3.1]nonane-2,4,9-trione
DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)
DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))
DG(8:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/8:0)
DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)
DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))
DG(8:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/8:0)
DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)
DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
DG(8:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))
DG(8:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/8:0)
DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.
2-Deoxy-5,20,26-trihydroxyecdysone 20,22-acetonide
3alpha-Angeloyloxy-2beta,15-dihydroxy-ent-labda-7,13E-dien-2-O-beta-xylopyranoside
Hyperforin
Hyperforin is a cyclic terpene ketone that is a prenylated carbobicyclic acylphloroglucinol derivative produced by St. Johns Wort, Hypericum perforatum. It has a role as a GABA reuptake inhibitor, a plant metabolite, an anti-inflammatory agent, an antidepressant, an antibacterial agent, an antineoplastic agent and an apoptosis inducer. It is a cyclic terpene ketone, a sesquarterpenoid and a carbobicyclic compound. Hyperforin is a phytochemical generated by the plants of the Hypericum family. One of the most important members of this family, due to its medical properties, is Hypericum perforatum, also known as St Johns wort. Hyperforin is a natural product found in Hypericum linarioides, Hypericum rumeliacum, and other organisms with data available. A cyclic terpene ketone that is a prenylated carbobicyclic acylphloroglucinol derivative produced by St. Johns Wort, Hypericum perforatum.
Bicyclo[3.3.1]non-3-ene-2,9-dione,4-hydroxy-6-methyl-1,3,7-tris(3-methyl-2-buten-1-yl)-5-(2-methyl-1-oxopropyl)-6-(4-methyl-3-penten-1-yl)-,(1R,5S,6R,7S)-
(2beta,3alpha,6alpha)-2,3,6,20,23,30-hexahydroxyurs-12-en-28-oic acid
2alpha,3beta-dihydroxy-9,9-dimethyl-3,4-(2,2-dimethyl-3beta-hydroxy-3,4-dihydro-2H-pyran)-8-(gamma,gamma-dimethylallyl)-2-(3-hydroxy-3-methylbutyl)-6-(1-oxo-2-methylpropyl)-8beta-H-cis-bicyclo[3.3.1]nona-1,5-dione|garcinielliptone H
3-sulfate of oleanolic acid|oleanolic acid 3-O-sulfate|oleanolic acid 3-sulfate|oleanolic acid sulfate
rel-Labd-12-en-15(16)-olid-7-one-8R-spiro-1鈥樎?-[2S-(2,4,5-trimethoxyphenyl)-3-cyclohexene]
2beta,3alpha,16alpha,20(R),24(S),25-hexahydroxy-9-methyl-19-norlanost-5-en-11,22-dione
1-(3,7-dimethylocta-2,6-dienyl)-6,6,10,10-tetramethyl-5-(1-methylethyl)-11-(2-methylpropanoyl)tetracyclo[7.3.1.13,11.03,7]tetradecane-2,12,14-trione|hypersampsone B
Lys Tyr Val Lys
Tyr Val Lys Lys
Lys Val Tyr Lys
1,2-Dilauroyl-sn-glycero-3-phosphate
A 1-acyl-2-dodecanoyl-sn-glycerol-3-phosphate in which the 1-acyl group is also dodecanoyl (lauroyl). Acquisition and generation of the data is financially supported in part by CREST/JST.
1,2-Dilauroyl-sn-Glycero-3-Phosphate Monosodium Salt
2-(hydroxymethyl)-6-(2,20,21-trihydroxydocosan-3-yloxy)oxane-3,4,5-triol
Glutamine conjugated cholic acid
((4R)-4-((3R,5R,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)lysine
C30H52N2O6 (536.3825171999999)
His Lys Pro Arg
His Lys Arg Pro
His Pro Lys Arg
His Pro Arg Lys
His Arg Lys Pro
His Arg Pro Lys
Lys His Pro Arg
Lys His Arg Pro
Lys Lys Val Tyr
Lys Lys Tyr Val
Lys Pro His Arg
Lys Pro Arg His
Lys Arg His Pro
Lys Arg Pro His
Lys Val Lys Tyr
Lys Tyr Lys Val
Pro His Lys Arg
Pro His Arg Lys
Pro Lys His Arg
Pro Lys Arg His
Pro Arg His Lys
Pro Arg Lys His
Arg His Lys Pro
Arg His Pro Lys
Arg Lys His Pro
Arg Lys Pro His
Arg Pro His Lys
Arg Pro Lys His
Val Lys Lys Tyr
Val Lys Tyr Lys
Val Tyr Lys Lys
Tyr Lys Lys Val
Tyr Lys Val Lys
Cyclotricuspidogenin C
Cyclopassifloic acid A
Cyclopassifloic acid C
N-stearoyl-O-phosphocholineserine
C26H53N2O7P (536.3590197999999)
glas#24
An ascarosyloxycarboxylic acid beta-D-glucopyranosyl ester resulting from the formal esterification of the carboxy group of ascr#24 with the anomeric hydroxy group of beta-D-glucopyranose. It is a metabolite of the nematode Caenorhabditis elegans.
ST 30:3;O8
FMOC-(3S,4S)-4-AMINO-3-HYDROXY-PENTANOIC ACID DCHA
1,3-Bis[2,6-bis(1-ethylpropyl)phenyl]iMidazoliuM chloride, 98\\% IPentHCl
1-O-{(13R)-13-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]tetradecanoyl}-beta-D-glucopyranose
(2-Dodecanoyloxy-3-phosphonooxypropyl) dodecanoate
2,3,7,8,12,13,17,18-Octaethyl-22,24-dihydro-21H,23H-porphyrin
[3-carboxy-2-[(4E,7E,11E)-10-hydroperoxy-12-[6-[(E)-pent-2-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]dodeca-4,7,11-trienoyl]oxypropyl]-trimethylazanium
[3-carboxy-2-[3-[6-[(1Z,5E,8E,11E)-3-hydroperoxytetradeca-1,5,8,11-tetraenyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]propanoyloxy]propyl]-trimethylazanium
[3-carboxy-2-[(E)-6-[6-[(1E,5Z,8E)-3-hydroperoxyundeca-1,5,8-trienyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hex-4-enoyl]oxypropyl]-trimethylazanium
sodium globostellatate D
An organic sodium salt that is the monosodium salt of globostellatic acid D. Isolated from the marine sponge Stelletta globostellata, it exhibits cytotoxicity against P-388 murine leukemia cells.
[(E)-[(1R,4aR,4bS,8aS,10aS)-1-[2-(furan-3-yl)ethyl]-4b,8,8,10a-tetramethyl-1,3,4,4a,5,6,7,8a,9,10-decahydrophenanthren-2-ylidene]methyl] sulfate;1,1-dimethylguanidine
17,24-epoxy-25-hydroxy-21-methoxy-3,4-secobaccharane
A natural product found in Aglaia foveolata.
(1R,5R,6R,7S)-6-Methyl-1,3,7-tris(3-methylbut-2-enyl)-5-(2-methyl-1-oxopropyl)-6-(4-methylpent-3-enyl)bicyclo[3.3.1]nonane-2,4,9-trione
2-[[(2R)-3-hexadecoxy-2-prop-2-enoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2R)-2-acetyloxy-3-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2,3-dihydroxypropyl [3-[(11Z,14Z)-henicosa-11,14-dienoxy]-2-hydroxypropyl] hydrogen phosphate
[2-(Heptanoylamino)-3-hydroxypentadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(nonanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tridecanoylamino)nonyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(octanoylamino)tetradecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(pentanoylamino)heptadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Butanoylamino)-3-hydroxyoctadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(propanoylamino)nonadecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Hexanoylamino)-3-hydroxyhexadecyl] 2-(trimethylazaniumyl)ethyl phosphate
(2-Acetamido-3-hydroxyicosyl) 2-(trimethylazaniumyl)ethyl phosphate
[2-(Dodecanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(undecanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate
[2-(Decanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate
[3-Hydroxy-2-(tetradecanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate
(1-Acetyloxy-3-phosphonooxypropan-2-yl) docosanoate
(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate
(1-Phosphonooxy-3-propanoyloxypropan-2-yl) henicosanoate
(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate
(1-Octanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate
(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) pentadecanoate
(1-Butanoyloxy-3-phosphonooxypropan-2-yl) icosanoate
(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate
(1-Decanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate
(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) tridecanoate
2-(Hydroxymethyl)-6-(2,20,21-trihydroxydocosan-3-yloxy)oxane-3,4,5-triol
((4R)-4-((3R,5R,7R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)lysine
C30H52N2O6 (536.3825171999999)
(1R,5S,7S,8R)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-enyl)-8-(4-methylpent-3-enyl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione
[(2R)-2-decanoyloxy-3-phosphonooxypropyl] tetradecanoate
[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] tridecanoate
[3-[2,3-bis[[(4E,7E)-deca-4,7-dienoyl]oxy]propoxy]-1-carboxypropyl]-trimethylazanium
C30H50NO7+ (536.3587090000001)
[1-carboxy-3-[3-[(9E,11E,13E,15E)-henicosa-9,11,13,15-tetraenoyl]oxy-2-hydroxypropoxy]propyl]-trimethylazanium
C31H54NO6+ (536.3950924000001)
[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] tetradecanoate
[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] tridecanoate
2-[hydroxy-[2-pentanoyloxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium
[3-[3-butanoyloxy-2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
C30H50NO7+ (536.3587090000001)
2-[[3-acetyloxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-[(Z)-hexadec-9-enoxy]-2-propanoyloxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[3-butanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-pentanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
[3-[3-acetyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium
C30H50NO7+ (536.3587090000001)
2-[hydroxy-[2-hydroxy-3-[(Z)-nonadec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-propanoyloxypropoxy]phosphoryl]oxyethyl-trimethylazanium
2-[carboxy-[2-hydroxy-3-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]methoxy]ethyl-trimethylazanium
C30H50NO7+ (536.3587090000001)
2-[[2-hexanoyloxy-3-[(Z)-tridec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-acetyloxy-3-[(Z)-heptadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-butanoyloxy-3-[(Z)-pentadec-9-enoxy]propoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
1-(11Z,14Z-eicosadienoyl)-glycero-3-phospho-(1-sn-glycerol)
(1s,3s,4s,6s,7s,8r,11s,12s,14r,15r,16r)-15-[(2r,5s)-5,6-dihydroxy-5-isopropylhexan-2-yl]-4,6,14-trihydroxy-7,12,16-trimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
12,20-dihydroxy-22-[1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]-3,13,17-trimethyl-1-oxacyclodocosa-3,5,7,9,13,15-hexaen-2-one
3a,5a,7,8-tetrahydroxy-1-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(3e,5e,7e,9e,12r,13e,15e,17r,20s,22s)-12,20-dihydroxy-22-[(1r,2s)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]-3,13,17-trimethyl-1-oxacyclodocosa-3,5,7,9,13,15-hexaen-2-one
n-{15-[1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl}benzenecarboximidic acid
(3e)-3-{2-[(1r,1'r,2s,4'as,8'as)-5',5',8'a-trimethyl-3'-oxo-2-(2,4,5-trimethoxyphenyl)-1',4',4'a,6',7',8'-hexahydrospiro[cyclohexane-1,2'-naphthalen]-3-en-1'-yl]ethylidene}oxolan-2-one
(1s,3as,5as,7r,8s,9ar,9br,11ar)-3a,5a,7,8-tetrahydroxy-1-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
4-hydroxy-2-isopropyl-8,8-dimethyl-5-oxo-6,7-dihydrophenanthren-3-yl hexadecanoate
33,34-dihydroxy-5,22-diazapentacyclo[16.16.1.0¹,²².0²,²⁰.0⁵,³⁵]pentatriaconta-10,26,29,31-tetraene-18-carbaldehyde
(1s,3s,4s,6s,7s,8r,11s,12s,15r,16r)-4,6-dihydroxy-7,12,16-trimethyl-15-[(2s,3r,5s)-3,5,6-trihydroxy-5-isopropylhexan-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-7-carboxylic acid
(17z,19z,21z,23z,25z)-4,6,10,12,14,16-hexahydroxy-3,27,28-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
7,10-dihydroxy-2-{7-[3-(3-hydroxypentan-2-yl)oxiran-2-yl]-6-methylhepta-2,4-dien-2-yl}-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl acetate
n-[(1r,3r,6s,7r,8r,11s,12s,14r,15s,16r)-15-[(1r)-1-(dimethylamino)ethyl]-14-hydroxy-7-(hydroxymethyl)-7,12,16-trimethyl-18-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-6-yl]benzenecarboximidic acid
(1s,2r,10z,18r,20s,26z,29z,31e,33s,34s,35s)-33,34-dihydroxy-5,22-diazapentacyclo[16.16.1.0¹,²².0²,²⁰.0⁵,³⁵]pentatriaconta-10,26,29,31-tetraene-18-carbaldehyde
(3e,5z,7e,9e,12s,13e,15e,17r)-20-[(3s,4r)-2,4-dihydroxy-4-(3-hydroxyphenyl)-3-methylbutyl]-12-hydroxy-3,13,17-trimethyl-1-oxacycloicosa-3,5,7,9,13,15-hexaen-2-one
5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-9-(sulfooxy)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
4,6,10,12,14,16-hexahydroxy-3,27,28-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
3-[(1s,2s,6s)-2-[(3s)-5-{[(2r,3r,4r,5s)-3,4-dihydroxy-5-[(3-methylbut-2-enoyl)oxy]oxan-2-yl]oxy}-3-methylpentyl]-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl]propanoic acid
(3e,5e,7z,9e,12r,13e,15e,17r,20s,22s)-12,20-dihydroxy-22-[(1r,2s)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]-3,13,17-trimethyl-1-oxacyclodocosa-3,5,7,9,13,15-hexaen-2-one
11-(3,7-dimethylocta-2,6-dien-1-yl)-3-isopropyl-4,4,8,8-tetramethyl-9-(2-methylpropanoyl)tetracyclo[7.3.1.1⁷,¹¹.0¹,⁵]tetradecane-10,12,13-trione
(3e,5z,7e,9z,12r,13e,15e,17r,20s,22s)-12,20-dihydroxy-22-[(1r,2s)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]-3,13,17-trimethyl-1-oxacyclodocosa-3,5,7,9,13,15-hexaen-2-one
3,6,7-trihydroxy-7-(3-hydroxy-3-methylbutyl)-4,4,10,10-tetramethyl-11-(3-methylbut-2-en-1-yl)-9-(2-methylpropanoyl)-5-oxatricyclo[7.3.1.0¹,⁶]tridecane-8,13-dione
3-{2-[5',5',8'a-trimethyl-3'-oxo-2-(2,4,5-trimethoxyphenyl)-1',4',4'a,6',7',8'-hexahydrospiro[cyclohexane-1,2'-naphthalen]-3-en-1'-yl]ethylidene}oxolan-2-one
(1r,3as,5ar,5br,7ar,9s,11ar,11br,13ar,13br)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-9-(sulfooxy)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
(2e)-3-[(1s,2r,4as,5r,8s,8ar)-5-hydroxy-4a,8-dimethyl-2-[(2e,5s,7r,9r,10s,11s)-5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl]-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid
2,2,6a,6b,9,9,12a-heptamethyl-10-(sulfooxy)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(2e,4e)-n-[(1s,2r)-2-hydroxy-1-{[(3z,5r,8s,10s)-2,7,10-trihydroxy-5-(hydroxymethyl)-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}propyl]dodeca-2,4-dienimidic acid
C27H44N4O7 (536.3209833999999)
2-{[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydro-1-benzopyran-6-yl]oxy}cyclohexa-2,5-diene-1,4-dione
2-{[17-(3,5-dihydroxyphenyl)-3-methylheptadeca-12,14-dien-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(3e,5e,7z,9z,12r,13e,15e,17r,20s,22s)-12,20-dihydroxy-22-[(1r,2s)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]-3,13,17-trimethyl-1-oxacyclodocosa-3,5,7,9,13,15-hexaen-2-one
(1s,3s,6r,7s,9r,11s)-3,6,7-trihydroxy-7-(3-hydroxy-3-methylbutyl)-4,4,10,10-tetramethyl-11-(3-methylbut-2-en-1-yl)-9-(2-methylpropanoyl)-5-oxatricyclo[7.3.1.0¹,⁶]tridecane-8,13-dione
(3z,5e,7e,9e,12s,13e,15e,17r,20s,22s)-12,20-dihydroxy-22-[(1r,2r)-1-hydroxy-1-(3-hydroxyphenyl)propan-2-yl]-3,13,17-trimethyl-1-oxacyclodocosa-3,5,7,9,13,15-hexaen-2-one
(3e,5e,7z,9e,12s,13e,15e,17r)-20-[(3s,4r)-2,4-dihydroxy-4-(3-hydroxyphenyl)-3-methylbutyl]-12-hydroxy-3,13,17-trimethyl-1-oxacycloicosa-3,5,7,9,13,15-hexaen-2-one
(3r,4r,6r,10s,12s,14s,16s,17e,19e,21e,23e,25e,27s,28s)-4,6,10,12,14,16-hexahydroxy-3,27,28-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
(1s,3as,5ar,7r,8s,9ar,9br,11ar)-1-[(1r)-1-[(2r,4r,5s,6s)-4-ethyl-4-hydroxy-6-methoxy-5-methyloxan-2-yl]-1-hydroxyethyl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1r,3as,5ar,5br,7ar,9r,11ar,11br,13ar,13br)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-9-(sulfooxy)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid
1-[5-(3,4-dihydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-3a,7,8-trihydroxy-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
1-(5,6-dimethylhept-3-en-2-yl)-5,5a,7,8,9b-pentahydroxy-9a-(hydroxymethyl)-11a-methyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-10-yl acetate
(2s,3s,4ar,5r,8as)-5-[(3e)-5-hydroxy-3-methylpent-3-en-1-yl]-1,1,4a,6-tetramethyl-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}-2,3,4,5,8,8a-hexahydronaphthalen-2-yl (2z)-2-methylbut-2-enoate
(2s,3r,4s,5s,6r)-2-{[(3s,4r,12e,14e)-17-(3,5-dihydroxyphenyl)-3-methylheptadeca-12,14-dien-4-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
(1s,5s,7r,8s)-4-hydroxy-8-methyl-3,5,7-tris(3-methylbut-2-en-1-yl)-8-(4-methylpent-3-en-1-yl)-1-(2-methylpropanoyl)bicyclo[3.3.1]non-3-ene-2,9-dione
(2e,4e)-10-hydroxy-n-(2-hydroxy-1-{[(3z)-2,7,10-trihydroxy-5-methyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}propyl)dodeca-2,4-dienimidic acid
C27H44N4O7 (536.3209833999999)
(4e)-7,10-dihydroxy-2-[(2e,4e)-7-[3-(3-hydroxypentan-2-yl)oxiran-2-yl]-6-methylhepta-2,4-dien-2-yl]-3,7-dimethyl-12-oxo-1-oxacyclododec-4-en-6-yl acetate
3-{2-[5-({3,4-dihydroxy-5-[(3-methylbut-2-enoyl)oxy]oxan-2-yl}oxy)-3-methylpentyl]-1,3-dimethyl-6-(prop-1-en-2-yl)cyclohex-3-en-1-yl}propanoic acid
[(2r,3r,4r,5r,6s)-3-(acetyloxy)-6-{[(5e)-6-[(1s,3e,7e)-4,8-dimethylcyclodeca-3,7-dien-1-yl]-2-methylhept-5-en-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]methyl acetate
3a,7,8,9-tetrahydroxy-1-[5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-(sulfooxy)-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid
(1s,3as,5ar,7r,8r,9s,9ar,9br,11ar)-3a,7,8,9-tetrahydroxy-1-[(4r,5r)-5-(3-hydroxy-3-methylbutyl)-2,2,4-trimethyl-1,3-dioxolan-4-yl]-9a,11a-dimethyl-1h,2h,3h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
(1r,3ar,5r,5ar,7r,8r,9ar,9br,10r,11ar)-1-[(2r,3e,5s)-5,6-dimethylhept-3-en-2-yl]-5,5a,7,8,9b-pentahydroxy-9a-(hydroxymethyl)-11a-methyl-1h,2h,3h,3ah,5h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-10-yl acetate
(17e,19e,21e,23e,25e)-4,6,10,12,14,16-hexahydroxy-3,27,28-trimethyl-1-oxacyclooctacosa-17,19,21,23,25-pentaen-2-one
(1s,3r,5r,7r,9s,11r)-11-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3-isopropyl-4,4,8,8-tetramethyl-9-(2-methylpropanoyl)tetracyclo[7.3.1.1⁷,¹¹.0¹,⁵]tetradecane-10,12,13-trione
[(2r,3s,4s,5r,6s)-4-(acetyloxy)-6-{[(5e)-6-[(1s,3e,7e)-4,8-dimethylcyclodeca-3,7-dien-1-yl]-2-methylhept-5-en-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]methyl acetate
(1s,3as,5as,7s,9ar,9br,11ar)-1-[(4r,5r)-5-[(3s)-3,4-dihydroxy-3-methylbutyl]-2,2,4-trimethyl-1,3-dioxolan-4-yl]-3a,5a,7-trihydroxy-9a,11a-dimethyl-1h,2h,3h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-5-one
3-[5-hydroxy-4a,8-dimethyl-2-(5,7,9,11-tetrahydroxy-10,12-dimethyltridec-2-en-2-yl)-2,5,6,7,8,8a-hexahydro-1h-naphthalen-1-yl]-2-methylprop-2-enoic acid
2-{[2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-3,4-dihydro-1-benzopyran-6-yl]oxy}cyclohexa-2,5-diene-1,4-dione
(2e,4e)-7-hydroxy-n-(2-hydroxy-1-{[(3z)-2,7,10-trihydroxy-5-methyl-1,6-diazacyclododeca-1,3,6-trien-8-yl]-c-hydroxycarbonimidoyl}propyl)dodeca-2,4-dienimidic acid
C27H44N4O7 (536.3209833999999)